West Pharmaceutical
592 hedge funds and large institutions have $19.7B invested in West Pharmaceutical in 2020 Q4 according to their latest regulatory filings, with 86 funds opening new positions, 238 increasing their positions, 195 reducing their positions, and 62 closing their positions.
39% more first-time investments, than exits
New positions opened: 86 | Existing positions closed: 62
22% more repeat investments, than reductions
Existing positions increased: 238 | Existing positions reduced: 195
3% more funds holding
Funds holding: 573 → 592 (+19)
5% more capital invested
Capital invested by funds: $18.8B → $19.7B (+$888M)
0.37% more ownership
Funds ownership: 92.85% → 93.22% (+0.37%)
18% less call options, than puts
Call options by funds: $16.9M | Put options by funds: $20.5M
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APG Asset Management
Amsterdam,
Netherlands
|
+$191M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$106M |
| 3 |
BlackRock
New York
|
+$98.5M |
| 4 |
WCM Investment Management
Laguna Beach,
California
|
+$67.5M |
| 5 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$56.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$133M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$89.2M |
| 3 |
Neuberger Berman Group
New York
|
-$77.8M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$51.5M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$51.2M |
WST Hedge Fund Activity: Q4 2020 in Review
592 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q4 2020, worth a combined $19.7B — up 4.7% from $18.8B a quarter earlier.
Buyers outnumbered sellers: 86 funds opened new WST positions and 62 closed out — a net gain of 24 holders — while 238 added to existing stakes and 195 trimmed.
The largest buyer was APG Asset Management, adding an estimated $191M. The largest seller was 1832 Asset Management, exiting entirely with an estimated $133M sold.
- 592 institutional investors held West Pharmaceutical (WST) as of Q4 2020, up from 573 in Q3 2020.
- Funds reported $19.7B of West Pharmaceutical stock for Q4 2020, up 4.7% quarter-over-quarter.
- 86 funds opened new West Pharmaceutical positions in Q4 2020 and 62 closed out, a net change of +24 holders.
- The largest West Pharmaceutical buyer in Q4 2020 was APG Asset Management, an estimated $191M added.
- The largest West Pharmaceutical seller in Q4 2020 was 1832 Asset Management, an estimated $133M sold.
Based on aggregated 13F filings for Q4 2020.